Moderna gets further $472 million US award for coronavirus vaccine development

Moderna gets further $472 million US award for coronavirus vaccine development

Moderna gets further $472 million US award for coronavirus vaccine development

Moderna gets further $472 million US award for coronavirus vaccine development

The US government awarded another $472m to US biotech Moderna to support the phase 3 clinical trials on July 26, 2020. (File/AFP)

Short Url

Moderna gets further $472 million US award for coronavirus vaccine development

The funding will support late-stage clinical development of the vaccine and the phase 3 trials.

Updated 26 July 2020

Follow @arabnews

WASHINGTON D.C: Moderna Inc. said on Sunday it has received an additional $472 million from the US government's Biomedical Advanced Research and Development Authority (BARDA) to support development of its novel coronavirus vaccine.

The US-based drug maker said the additional funding will support its late-stage clinical development including the expanded Phase 3 study of Moderna's vaccine candidate.

In April, Moderna had received $483 million from the US federal agency that funds disease-fighting technology, when the experimental vaccine was in an early-stage trial conducted by the US National Institutes of Health.

"Encouraged by the Phase 1 data, we believe that our mRNA vaccine may aid in addressing the COVID-19 pandemic and preventing future outbreaks,“ Chief Executive Officer Stéphane Bancel said in a press release.

BARDA's total funding for the experimental vaccine of Moderna, the first